Page last updated: 2024-08-23

zidovudine and Acute Myelogenous Leukemia

zidovudine has been researched along with Acute Myelogenous Leukemia in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assaraf, YG; Berman, B; Levin, M; Stark, M1
Brown, TR1
Cloos, L; Hofbauer, R; Mortensen, BT; Munch-Petersen, B; Tyrsted, G; Völker, C1
Kane, D; Keating, S; McCann, S; Mulcahy, F1
Najfeld, V; Scalise, A; Silverman, L; Theodossiou, C1
ten Kate, RW; Wijermans, PW1
Blau, IW; Elstner, E; Ihle, R; Langen, P; von Janta-Lipinski, M; Waechter, M1

Reviews

1 review(s) available for zidovudine and Acute Myelogenous Leukemia

ArticleYear
The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review.
    International journal of STD & AIDS, 1997, Volume: 8, Issue:4

    Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cytarabine; Daunorubicin; Drug Therapy, Combination; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Thioguanine; Zidovudine

1997

Other Studies

6 other study(ies) available for zidovudine and Acute Myelogenous Leukemia

ArticleYear
Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.
    Cell death & disease, 2019, 05-17, Volume: 10, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cytarabine; Deoxycytidine Kinase; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Histones; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Ubiquitination; Zidovudine

2019
I am the Berlin patient: a personal reflection.
    AIDS research and human retroviruses, 2015, Volume: 31, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Berlin; CD4-Positive T-Lymphocytes; History, 20th Century; History, 21st Century; Humans; Leukemia, Myeloid, Acute; Male; Receptors, CCR5; Stem Cell Transplantation; Survival; Treatment Outcome; Zidovudine

2015
Altered substrate and inhibitor specificity of purified human adult thymidine kinases (TK2) from leukemic cells.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Adult; Cell Line; Floxuridine; Humans; Isoenzymes; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Reference Values; Substrate Specificity; Thymidine Kinase; Thymine Nucleotides; Tumor Cells, Cultured; Zidovudine

1994
Chromosome 21 rearrangement in acute biphenotypic leukemia.
    Cancer genetics and cytogenetics, 1992, Volume: 64, Issue:1

    Topics: Anemia, Refractory, with Excess of Blasts; Antigens, CD; Antigens, Differentiation, Myelomonocytic; CD13 Antigens; Cell Transformation, Neoplastic; Cholecalciferol; Chromosomes, Human, Pair 21; Gene Expression Regulation, Leukemic; Gene Rearrangement; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Receptors, Interleukin-2; Trisomy; Zidovudine

1992
Successful chemotherapy for acute myeloid leucaemia in HIV-infected patients.
    European journal of haematology, 1990, Volume: 44, Issue:2

    Topics: CD4 Antigens; Cytarabine; HIV Antibodies; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Zidovudine

1990
Sensitivity of CFU-GM from normal human bone marrow and leukaemic clonogenic cells (CFU-L) from blood of patients with myelogenous leukaemia to 3'-deoxy-3'-fluorothymidine in comparison to 3'-azido-3'-deoxythymidine.
    Blut, 1989, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Cells; Dideoxynucleosides; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Zidovudine

1989